Bupropion and naltrexone and Fleet Glycerin Suppositories Pediatric rectal
Determining the interaction of Bupropion and naltrexone and Fleet Glycerin Suppositories Pediatric rectal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion / naltrexone
Brand name: Contrave
Synonyms: Naltrexone and Bupropion
Generic Name: glycerin
Brand name: Fleet Glycerin Suppositories Adult, Fleet Glycerin Suppositories Pediatric, Pedia-Lax Liquid, Sani-Supp, Osmoglyn, Fleet Babylax, Glycerin Suppositories Maximum Strength, Colace Glycerin Suppositories, Tixylix Baby, Glycerol Adult, Senokot Direct Relief, Glycerol, Ichthammol Glycerin, Ravin, Glycerol Infant, Glycerol Pediatric, Boots Cough Syrup 3 Months Plus, Gilseal Homecare Glycerol BP, Allens Junior Cough, Bandi S15, Avedana Glycerin Suppositories Adult
Synonyms: Fleet Glycerin Suppositories Pediatric (rectal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion and naltrexone-Fleet Phospho-soda EZ-Prep Oral
- Bupropion and naltrexone-Fletchers Castoria
- Bupropion and naltrexone-Flex-All 454 Maximum Strength
- Bupropion and naltrexone-Flexeril
- Bupropion and naltrexone-Flextra
- Bupropion and naltrexone-Flextra 650
- Fleet Glycerin Suppositories Pediatric rectal-Bupropion Extended-Release Tablets
- Fleet Glycerin Suppositories Pediatric rectal-Bupropion Hydrochloride
- Fleet Glycerin Suppositories Pediatric rectal-Bupropion SR Tablets
- Fleet Glycerin Suppositories Pediatric rectal-Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Fleet Glycerin Suppositories Pediatric rectal-Bupropion Tablets
- Fleet Glycerin Suppositories Pediatric rectal-Bupropion Tablets and Sustained-Release Tablets